Previous Close | 51.30 |
Open | 51.10 |
Bid | 51.02 x 0 |
Ask | 51.38 x 0 |
Day's Range | 51.06 - 51.26 |
52 Week Range | 45.64 - 57.86 |
Volume | |
Avg. Volume | 76 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Nov 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
TARRYTOWN, N.Y., October 15, 2024--A new prognosis claim for the Siemens Healthineers Atellica IM High-Sensitivity Troponin I (TnIH) test1 immediately advances care for at-risk cardiac patients in the U.S. The easy blood test helps healthcare providers identify patients at risk of death and major cardiac events that could occur up to one year after presenting to the emergency department with signs and symptoms of acute coronary syndrome. It is the first test of its kind in the United States to r
Stock pickers are generally looking for stocks that will outperform the broader market. Buying under-rated businesses...